The acute invasive aspergillosis treatment market is witnessing substantial growth due to the increasing prevalence of fungal infections, rising immunocompromised patient populations, and growing advancements in antifungal therapies. Acute invasive aspergillosis is a severe fungal infection primarily affecting individuals with weakened immune systems, including cancer patients, organ transplant...